Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
1.030
+0.020 (1.98%)
Apr 6, 2026, 10:05 AM EDT - Market open
Werewolf Therapeutics Market Cap
Werewolf Therapeutics has a market cap or net worth of $50.05 million as of April 6, 2026. Its market cap has decreased by -1.18% in one year.
Market Cap
50.05M
Enterprise Value
4.87M
1-Year Change
-1.18%
Ranking
Category
Stock Price
$1.03
Market Cap Chart
Since the IPO on April 30, 2021, Werewolf Therapeutics's market cap has decreased from $440.42M to $50.05M, a decrease of -88.63%. That is a compound annual growth rate of -35.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 49.08M | 59.62% |
| Dec 31, 2025 | 30.75M | -53.38% |
| Dec 31, 2024 | 65.95M | -52.79% |
| Dec 29, 2023 | 139.70M | 121.66% |
| Dec 30, 2022 | 63.03M | -80.81% |
| Dec 31, 2021 | 328.47M | -25.42% |
| Apr 30, 2021 | 440.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OS Therapies | 53.77M |
| NovaBay Pharmaceuticals | 51.92M |
| Radiopharm Theranostics | 51.41M |
| Edesa Biotech | 51.26M |
| Mereo BioPharma Group | 51.08M |
| Metagenomi Therapeutics | 50.79M |
| MiNK Therapeutics | 50.18M |
| Aligos Therapeutics | 49.32M |